Cell to Induce X-Linked Immunodeficiency B and Synergizes with B Cell Receptor Signals Mitogen-Activated Protein Kinase Activation Positive Signaling Through CD72 Induces

CD72 is a 45-kDa B cell transmembrane glycoprotein that has been shown to be important for B cell activation. However, whether CD72 ligation induces B cell activation by delivering positive signals or sequestering negative signals away from B cell receptor (BCR) signals remains unclear. Here, by comparing the late signaling events associated with the mitogen-activated protein kinase pathway, we identified many similarities and some differenes between CD72 and BCR signaling. Thus, CD72 and BCR activated the extracellular signal-regulated kinase (ERK) and the c-Jun N-terminal kinase (JNK) but not p38 mitogen-activated protein kinase. Both CD72- and BCR-mediated ERK and JNK activation required protein kinase C activity, which was equally important for CD72- and BCR-induced B cell proliferation. However, CD72 induced stronger JNK activation compared with BCR. Sur-prisingly, the JNK activation induced by both BCR and CD72 is Btk independent. Although both CD72 and BCR induced Btk-dependent ERK activation, CD72-mediated proliferation is more resistent to blocking of ERK activity than that of BCR, as shown by the proliferation response of B cells treated with PD98059 and dibutyryl cAMP, agents that inhibit ERK activity. Most importantly, CD72 signaling compensated for defective BCR signaling in X-linked immunodeficiency B cells and partially restored the proliferation response of X-linked immunodeficiency B cells to anti-IgM ligation. These results suggest that CD72 signals B cells by inducing BCR-independent positive signaling pathways. The Journal of Immunology, 2001, 167: 1263–1273. ERK pathway, we show a differential requirement of ERK for CD72- and BCR-induced B cell proliferation. CD72 and BCR acted in synergy to induce proliferation of X-linked immunodeficiency (Xid) B cells, suggesting that they have independent roles in B cell activation.

[1]  M. Ikawa,et al.  The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice. , 2000, Immunity.

[2]  M. Matsumoto,et al.  Identification of CD72 as a lymphocyte receptor for the class IV semaphorin CD100: a novel mechanism for regulating B cell signaling. , 2000, Immunity.

[3]  R. Davis,et al.  Signal Transduction by the JNK Group of MAP Kinases , 2000, Cell.

[4]  S. Tomita,et al.  BLNK is associated with the CD72 / SHP‐1 / Grb2 complex in the WEHI231 cell line after membrane IgM cross‐linking , 2000, European journal of immunology.

[5]  Christopher C. Goodnow,et al.  How self-tolerance and the immunosuppressive drug FK506 prevent B-cell mitogenesis , 2000, Nature.

[6]  T. Adachi,et al.  CD72 Negatively Regulates Signaling Through the Antigen Receptor of B Cells1 , 2000, The Journal of Immunology.

[7]  Gunther Hartmann,et al.  Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells1 , 2000, The Journal of Immunology.

[8]  M. Gold Intermediary signaling effectors coupling the B-cell receptor to the nucleus. , 2000, Current topics in microbiology and immunology.

[9]  N. Baumgarth,et al.  CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. , 1999, Immunity.

[10]  E. Gelfand,et al.  Differential activation and regulation of mitogen‐activated protein kinases through the antigen receptor and CD40 in human B cells , 1999, European journal of immunology.

[11]  E. Wagner,et al.  JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development , 1999, Current Biology.

[12]  R. Flavell,et al.  Defective T cell differentiation in the absence of Jnk1. , 1998, Science.

[13]  T. Kurosaki,et al.  Involvement of Guanosine Triphosphatases and Phospholipase C-γ2 in Extracellular Signal–regulated Kinase, c-Jun NH2-terminal Kinase, and p38 Mitogen-activated Protein Kinase Activation by the B Cell Antigen Receptor , 1998, The Journal of experimental medicine.

[14]  T. Kurosaki,et al.  Different Protein Tyrosine Kinases Are Required for B Cell Antigen Receptor–mediated Activation of Extracellular Signal–Regulated kinase, c-Jun NH2-terminal Kinase 1, and p38 Mitogen-activated Protein Kinase , 1998, The Journal of experimental medicine.

[15]  R. Flavell,et al.  Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. , 1998, Immunity.

[16]  J. Cambier,et al.  Interleukin-4 overcomes the negative influence of cyclic AMP accumulation on antigen receptor stimulated B lymphocytes. , 1998, Molecular immunology.

[17]  T. Pawson,et al.  The B-cell transmembrane protein CD72 binds to and is an in vivo substrate of the protein tyrosine phosphatase SHP-1 , 1998, Current Biology.

[18]  A. Satterthwaite,et al.  Btk function in B cell development and response. , 1998, Seminars in immunology.

[19]  F. Hobbs,et al.  Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.

[20]  C. Turck,et al.  BLNK: a central linker protein in B cell activation. , 1998, Immunity.

[21]  E. Krebs,et al.  A comparison of signaling requirements for apoptosis of human B lymphocytes induced by the B cell receptor and CD95/Fas. , 1998, Journal of immunology.

[22]  M. Reth,et al.  The B cell surface protein CD72 recruits the tyrosine phosphatase SHP-1 upon tyrosine phosphorylation. , 1998, Journal of immunology.

[23]  T. Kurosaki,et al.  Requirement of SH2-containing Protein Tyrosine Phosphatases SHP-1 and SHP-2 for Paired Immunoglobulin-like Receptor B (PIR-B)–mediated Inhibitory Signal , 1998, The Journal of experimental medicine.

[24]  N. Muthusamy,et al.  Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes. , 1998, Journal of immunology.

[25]  Ching-shih Chen,et al.  CD72‐mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3‐kinase , 1998, European journal of immunology.

[26]  D. Parker,et al.  Differential coupling of membrane Ig and CD40 to the extracellularly regulated kinase signaling pathway. , 1998, Journal of Immunology.

[27]  W. Kolch,et al.  Epstein–Barr virus latent membrane protein‐1 triggers AP‐1 activity via the c‐Jun N‐terminal kinase cascade , 1997, The EMBO journal.

[28]  A. Ashworth,et al.  A role for JNK/SAPK in proliferation, but not apoptosis, of IL-3-dependent cells , 1997, Current Biology.

[29]  K. Rajewsky,et al.  In Vivo Ablation of Surface Immunoglobulin on Mature B Cells by Inducible Gene Targeting Results in Rapid Cell Death , 1997, Cell.

[30]  T. Kurosaki,et al.  Deletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling , 1997, Cell.

[31]  P. Youinou,et al.  Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells. , 1997, International immunology.

[32]  K. Brorson,et al.  xid affects events leading to B cell cycle entry. , 1997, Journal of immunology.

[33]  G. Crabtree,et al.  Different nuclear signals are activated by the B cell receptor during positive versus negative signaling. , 1997, Immunity.

[34]  M. Inaoki,et al.  The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. , 1997, Immunity.

[35]  G. Köhler,et al.  CD22 is a negative regulator of B-cell receptor signalling , 1997, Current Biology.

[36]  K. Schuebel,et al.  Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.

[37]  R. Perlmutter,et al.  CD22 regulates thymus-independent responses and the lifespan of B cells , 1996, Nature.

[38]  S. Bondada,et al.  CD5-Mediated Negative Regulation of Antigen Receptor-Induced Growth Signals in B-1 B Cells , 1996, Science.

[39]  A. Miller,et al.  CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: altered signaling in CD22-deficient mice. , 1996, Immunity.

[40]  M. Neuberger,et al.  Hyperresponsive B Cells in CD22-Deficient Mice , 1996, Science.

[41]  C. Nobes,et al.  Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways , 1996, Current Biology.

[42]  M. Gold,et al.  Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor. , 1996, Journal of immunology.

[43]  G. Bishop,et al.  CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells. , 1996, Journal of immunology.

[44]  Wei Wei Wu,et al.  Induction of cell cycle regulatory proteins in anti-immunoglobulin- stimulated mature B lymphocytes , 1996, The Journal of experimental medicine.

[45]  S. Korsmeyer,et al.  Regulation of B cell survival in xid mice by the proto-oncogene bcl-2. , 1996, Journal of immunology.

[46]  J. Woodgett,et al.  Cross‐linking CD40 on B cells preferentially induces stress‐activated protein kinases rather than mitogen‐activated protein kinases. , 1996, The EMBO journal.

[47]  T. Mak,et al.  Immunoglobulin-mediated signal transduction in B cells from CD45- deficient mice , 1996, The Journal of experimental medicine.

[48]  Philip R. Cohen,et al.  PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[49]  N. Solvason,et al.  Murine CD38: an immunoregulatory ectoenzyme. , 1995, Immunology today.

[50]  F. Alt,et al.  Defective B cell development and function in Btk-deficient mice. , 1995, Immunity.

[51]  D. Fearon,et al.  A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. , 1995, Science.

[52]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  J. Monroe,et al.  Engagement of the antigen-receptor on immature murine B lymphocytes results in death by apoptosis. , 1995, Journal of immunology.

[54]  J. Gordon,et al.  B-cell signalling via the C-type lectins CD23 and CD72. , 1994, Immunology today.

[55]  J. Kehrl,et al.  Differential expression of a novel protein kinase in human B lymphocytes. Preferential localization in the germinal center. , 1994, The Journal of biological chemistry.

[56]  M. Cobb,et al.  MAP kinases ERK1 and ERK2: pleiotropic enzymes in a ubiquitous signaling network. , 1994, Advances in cancer research.

[57]  J. Banchereau,et al.  The CD40 antigen and its ligand. , 1994, Annual review of immunology.

[58]  J. Cambier,et al.  Signal transduction by the B cell antigen receptor and its coreceptors. , 1994, Annual review of immunology.

[59]  M. Neuberger,et al.  Association of CD22 with the B cell antigen receptor , 1993, European journal of immunology.

[60]  R. Geahlen,et al.  CD22 associates with the human surface IgM-B-cell antigen receptor complex. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M. Gold,et al.  Selective activation of p42 mitogen-activated protein (MAP) kinase in murine B lymphoma cell lines by membrane immunoglobulin cross-linking. Evidence for protein kinase C-independent and -dependent mechanisms of activation. , 1992, The Biochemical journal.

[62]  W. Fridman,et al.  Cytoplasmic domain heterogeneity and functions of IgG Fc receptors in B lymphocytes. , 1992, Science.

[63]  C. June,et al.  Biochemical analysis of the immune B cell defect in xid mice. , 1991, Journal of immunology.

[64]  N. Muthusamy,et al.  Differential regulation of surface Ig- and Lyb2-mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. , 1991, Journal of immunology.

[65]  H. Coste,et al.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. , 1991, The Journal of biological chemistry.

[66]  M. Harnett,et al.  Analysis of signaling via surface immunoglobulin receptors on b cells from cba/n mice , 1989, European journal of immunology.

[67]  W. Paul,et al.  Differential induction of class II gene expression in murine pre-B-cell lines by B-cell stimulatory factor-1 and by antibodies to B-cell surface antigens. , 1988, The Journal of molecular and cellular immunology : JMCI.

[68]  E. C. Snow,et al.  The phosphatidylinositol response is an early event in the physiologically relevant activation of antigen-specific B lymphocytes. , 1987, Cellular immunology.

[69]  W. Paul,et al.  Regulation of Growth and Proliferation in B Cell Subpopulations , 1982, Immunological reviews.